Matches in UGent Biblio for { <https://biblio.ugent.be/publication/306078#aggregation> ?p ?o. }
Showing items 1 to 39 of
39
with 100 items per page.
- aggregation classification "C3".
- aggregation creator B109848.
- aggregation creator B109849.
- aggregation creator B109850.
- aggregation creator B109851.
- aggregation creator B109852.
- aggregation creator B109853.
- aggregation creator B109854.
- aggregation creator B109855.
- aggregation creator B109856.
- aggregation creator B109857.
- aggregation creator person.
- aggregation creator person.
- aggregation date "2003".
- aggregation hasFormat 306078.bibtex.
- aggregation hasFormat 306078.csv.
- aggregation hasFormat 306078.dc.
- aggregation hasFormat 306078.didl.
- aggregation hasFormat 306078.doc.
- aggregation hasFormat 306078.json.
- aggregation hasFormat 306078.mets.
- aggregation hasFormat 306078.mods.
- aggregation hasFormat 306078.rdf.
- aggregation hasFormat 306078.ris.
- aggregation hasFormat 306078.txt.
- aggregation hasFormat 306078.xls.
- aggregation hasFormat 306078.yaml.
- aggregation isPartOf urn:issn:1098-3015.
- aggregation language "eng".
- aggregation publisher "BLACKWELL PUBLISHING INC".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "Irbesartan is projected to be cost and life saving in the French setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria".
- aggregation authorList BK281003.
- aggregation endPage "616".
- aggregation issue "6".
- aggregation startPage "615".
- aggregation volume "6".
- aggregation isDescribedBy 306078.
- aggregation similarTo LU-306078.